Drug Discovery News
-
10 top global pharma firms join hands for drug discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2012
Singapore: Ten leading biopharmaceutical companies have formed a non-profit organization to accelerate the development ...Read more
-
Nuvilex, Lincoln Park Fund sign $27 mn stock deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Feb, 2014
Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment o...Read more
-
Korea to spend $8.9 bn to develop 20 drugs by 2017
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: South Korea will channelize a combined $8.9 billion (10 trillion Won) on developing 20 new drugs over the nex...Read more
-
Abbott reveals 10-year study data for HUMIRA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Singapore: Abbott revealed the results from two long-term, open-label studies, which evaluated the results of HUMIRA (ad...Read more
-
Edinburgh Univ, Biogen to study neuro diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Experts from University of Edinburgh, UK, and Massachusetts-based biotechnology company Biogen Idec have join...Read more
-
Admedus acquires Genzyme manufacturing site
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2013
Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufact...Read more
-
AstraZeneca halts development of obesity drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Singapore: Palatin Technologies collaboration with AstraZeneca is to be discontinued for the further development of AZD2...Read more
-
Trajenta shows blood glucose improvements
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Singapore: Results from a two-year study has demonstrated that Boehringer Ingelheim's Trajenta (linagliptin) provides si...Read more
-
Drug Discovery | Opinion | By Nandita Singh | 0 Comment | 01 Aug, 2012
VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF ...Read more
-
China invests $160 bn in biomedicine sector
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013
Singapore: A report filed by Lux Research that tracks emerging technologies has said that China has invested a staggerin...Read more
-
BioDiem gets positive results for eye disease drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem received positive results from ...Read more
-
Australia strengthens scientific collaboration with Indonesia
Drug Discovery | Influencers | By BioSpectrum Bureau | 3 Comment | 24 Apr, 2014
Singapore: Australian Academy of Science and the Indonesian Academy of Sciences have signed a new memorandum of understa...Read more
-
China, Taiwan firms join hands for cancer drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013
Singapore: Taiwan's PharmaEngine has signed research collaboration with Guangzhou BeBetter Medicine Technology to design...Read more
-
Amgen terminates AstraZeneca psoriasis drug partnership
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 27 May, 2015
Singapore: Amgen has terminated the partnership with AstraZeneca for co-development and commercialization of brodalumab,...Read more
-
UCLA finds new compound to curb Alzheimer's
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Nov, 2012
Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular...Read more
-
Dainippon, Nippon Shinyaku sign deal for new drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2013
Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have c...Read more
-
AVEO, Astellas file NDA for tivozanib
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2012
Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Dru...Read more
-
Sanofi seeks approval for Lyxumia in Japan
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 11 Jun, 2012
Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational ...Read more
